Nephros (NEPH) Liabilities from Discontinued Operations (2021 - 2022)
Nephros' (NEPH) quarterly Liabilities from Discontinued Operations came in at 130000.0 in Q3 2022, up 80.56% quarter-over-quarter from 72000.0 in Q4 2021.
Nephros (NEPH) Liabilities from Discontinued Operations (2021 - 2022) Analysis & Trends
Nephros' Liabilities from Discontinued Operations history runs 2 years deep, the most recent figure standing at 130000.0 for Q3 2022.
- On a quarterly basis, Liabilities from Discontinued Operations changed N/A year-over-year to 130000.0 in Q3 2022; TTM through Sep 2022 was 130000.0, a N/A change from a year earlier, with the FY2021 full-year figure at 72000.0, changed N/A from the prior year.
- Liabilities from Discontinued Operations improved to 130000.0 in Q3 2022 per NEPH's latest filing, from 72000.0 in the prior quarter.
- Across five years, Liabilities from Discontinued Operations topped out at 130000.0 in Q3 2022 and bottomed at 72000.0 in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 124.85 Bn | 119.63 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 44.44 Bn | 43.62 Bn | 2.15 Bn |
| 3 | Alcon | 33.01 Bn | 31.35 Bn | 1.53 Bn |
| 4 | Medline | 32.57 Bn | 30.34 Bn | 1.84 Bn |
| 5 | Resmed | 28.95 Bn | 27.29 Bn | 890.98 Mn |
| 6 | West Pharmaceutical Services | 23.58 Bn | 23.14 Bn | 329.20 Mn |
| 7 | Solventum | 13.90 Bn | 13.34 Bn | 1.10 Bn |
| 8 | Cooper Companies | 13.87 Bn | 13.73 Bn | 735.40 Mn |
| 9 | Align Technology | 12.18 Bn | 11.12 Bn | 736.59 Mn |
| 10 | Nephros | 38.88 Mn | 34.86 Mn | 2.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 130,000.00 |
| Sep 30, 2022 | 130,000.00 |
| Dec 31, 2021 | 72,000.00 |
| Dec 31, 2021 | 72,000.00 |